Palliative Care Phase: Inter-rater reliability and acceptability in a national study by Masso, Malcolm et al.
This is the author’s version of a work that was submitted/accepted for pub-
lication in the following source:
Masso, Malcolm, Allingham, Samuel Frederic, Banfield, Maree, Johnson,
Claire Elizabeth, Pidgeon, Tanya, Yates, Patsy, & Eagar, Kathy
(2015)
Palliative care phase : inter-rater reliability and acceptability in a national
study.
Palliative Medicine, 29(1), pp. 22-30.
This file was downloaded from: http://eprints.qut.edu.au/77713/
c© Copyright 2014 The Authors
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
http://dx.doi.org/10.1177/0269216314551814
2 
 
Abstract 
Background 
The concept of palliative care consisting of five distinct, clinically meaningful, phases 
(stable, unstable, deteriorating, terminal, bereavement) was developed in Australia 
about 20 years ago and is used routinely for communicating clinical status, care 
planning, quality improvement and funding. 
Aim 
To test the reliability and acceptability of revised definitions of Palliative Care Phase. 
Design 
Multi-centre cross-sectional study involving pairs of clinicians independently rating 
patients according to revised definitions of Palliative Care Phase.  
Setting/participants 
Clinicians from ten Australian palliative care services, including nine inpatient units and 
one mixed inpatient/community-based service. 
Results 
A total of 102 nursing and medical clinicians participated, undertaking 595 paired 
assessments of 410 patients, of which 90.7% occurred within two hours. Clinicians 
rated 54.8% of patients in the stable phase, 15.8% in the unstable phase, 20.8% in the 
deteriorating phase and 8.7% in the terminal phase. Overall agreement between 
clinicians’ rating of Palliative Care Phase was substantial (Kappa 0.67; 95% confidence 
interval 0.61 to 0.70). A moderate level of inter-rater reliability was apparent across all 
participating sites. The results indicated that Palliative Care Phase was an acceptable 
measure, with no significant difficulties assigning patients to a Palliative Care Phase 
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and a good fit between assessment of phase and the definition of that phase. The most 
difficult phase to distinguish from other phases was the deteriorating phase. 
Conclusions 
Policy makers, funders and clinicians can be confident that Palliative Care Phase is a 
reliable and acceptable measure that can be used for care planning, quality improvement 
and funding purposes.   
 
Key words 
Episode of care, needs assessment, palliative care, reproducibility of results, patient 
acuity 
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What is already known about this topic 
 The concept of palliative care consisting of distinct, clinically meaningful, phases 
was developed in Australia about 20 years ago and is widely used for 
communication of clinical status, care planning, quality improvement and funding. 
 Only one previous study regarding the inter-rater reliability of Palliative Care 
Phases has been conducted. 
What this paper adds 
 The study demonstrated a substantial level of inter-rater reliability when two 
clinicians assessed the same patient for Palliative Care Phase at approximately the 
same time. 
 The results indicate that there were no significant difficulties assigning patients to 
one of the four phases and a good fit between assessment of phase and the definition 
of phase. 
 The most difficult phase to distinguish from other phases was the deteriorating 
phase. 
Implications for practice, theory or policy  
 Palliative Care Phase is a reliable and acceptable measure which can be used with 
confidence to facilitate clinical communication, improve quality of care and fund 
services.  
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Introduction 
The Palliative Care Outcomes Collaboration (PCOC) was established in 2005 to support 
continuous improvement in palliative care with a combination of routine clinical 
outcome measurement, periodic surveys and benchmarking.1 Since then, PCOC has 
collected data on clinical outcomes from palliative care services across Australia using 
standardised clinical assessment tools. One of those tools, Palliative Care Phase (PC 
Phase),2,3 is the subject of this study.  
In 1993, the Australian Association for Hospice and Palliative Care held a 2-day 
national workshop for palliative care clinicians which resulted in the development of a 
draft casemix classification for palliative care.3 The classification described five 
distinct, clinically meaningful, phases of palliative care – stable phase, acute phase, 
deteriorating phase, terminal phase and a post-death bereavement phase – based on four 
palliative care principles: 
 In palliative care, the patient and carers are the unit of care. 
 In palliative care, the focus is on the patient’s needs, goals and priorities rather 
than the disease. 
 Palliative care patients have ‘episodes of care’ that include acute changes in 
condition. 
 Such ‘episodes’ must be applicable in community and inpatient settings, and 
reflect the resource implications of the care provided.4  
An episode of care is a period of contact between a patient and a palliative care service 
occurring in one setting e.g. inpatient unit, patient’s home. Given the unpredictable 
trajectory of many life limiting conditions, PC Phases do not necessarily represent a 
linear progression of disease; patients can move between phases in any direction. It was 
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proposed that the acute, stable and deteriorating phases could be determined by the 
presence or absence of three variables: problem-related variables, variables related to 
activities of daily living and variables related to the level of carer support. It was also 
proposed that in the terminal phase the level of carer support was likely to be the only 
variable ‘to cause significant variation in a clinical and resource sense’.3, p 2  
The classification system was tested in 1994,3 resulting in revisions to the initial 
definitions of the five phases to clarify the intention of the original concepts and make 
the definitions easier to use.2 The inter-rater reliability of the revised definitions was 
tested two years later resulting in a level of agreement of 0.736 and an associated kappa 
statistic of 0.52.2  
Further refinement led to replacement of the term ‘acute’ with ‘unstable’, resulting in 
the nomenclature that has been used to this day: stable, unstable, deteriorating, terminal, 
bereavement.2  These definitions were used in the development of the Australian 
National Sub-Acute and Non-Acute Patient (AN-SNAP) casemix classification, with 
PC Phase providing the foundation for developing classes for both inpatient and 
ambulatory palliative care.5,6  
Extensive consultation took place with palliative care providers in 2011 to revise the 
definitions of the PC Phases in response to clinician concerns that the existing 
definitions were not always clear. This resulted in the development of revised 
definitions based on how phases both start and end, whereas the previous definitions 
were based solely on how phases began. The revised definitions are now part of the 
PCOC education program and a toolkit including the revised definitions is available on 
the PCOC website. The revised definitions are included in Appendix 1. 
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These revised definitions prompted the need to test their reliability, which is the primary 
aim of this study. The secondary aim is to test the acceptability of the revised 
definitions, by seeking feedback on ease of use and the ‘fit’ between the PC Phase 
assigned to a patient and the definition of that phase. 
Methods 
The study involved a convenience sample of ten palliative care services in two states of 
Australia, of which nine were inpatient services and one a mixed inpatient/community-
based service. Nine of the services had been collecting data on PC Phase for over five 
years. The services ranged from small rural services to large metropolitan services. Data 
collection took place from March to June 2013. 
Study coordinators at each site invited clinicians to participate, provided instructions to 
participating clinicians and managed on-site data collection. Study coordinators 
maintained a list of participating clinicians and a Clinician ID, unique to each clinician, 
for the purposes of the study. Clinicians with little or no knowledge of the patients were 
excluded (e.g. returning from a period of extended leave). Participants were requested to 
provide a small amount of demographic information: job title, profession, length of 
clinical experience and any training in use of the tools. 
The study involved two clinicians independently assessing each patient according to the 
revised definitions of each PC Phase, with a maximum of two hours between the two 
assessments used as a guide to those participating in the study. It was left to the 
discretion of each service as to how this was organised. Participants were requested not 
to discuss their assessments with each other. Data were collected on specified days, at 
least one week apart (to ensure that a range of different patients were assessed), with a 
data collection form used to collect data on: 
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a) The assessment of the patient according to the PC Phase. 
b) How well the assessment ‘fitted’ the needs of the patient (on a 5-point scale 
from 0-4) 
c) The ease of assigning a PC Phase to the patient (on a 5-point scale from 0-4). 
The scales for degree of ‘fit’ and ease of assignment, with minor modification, were 
based on scales used in a previous study to test the reliability of case types in sub-acute 
care.7 Four of the five PC Phases were tested in the study. The bereavement phase, 
which is used after the patient has died, was excluded. 
Completed assessments were collected from the study site by the research team. Data 
were entered into an Access database and uploaded into SAS 9.2 and Excel for analysis. 
The medical record number for each patient was used to link the assessment data 
(collected as part of this study) with demographic data routinely collected and provided 
to PCOC every six months by the study sites. 
At the conclusion of data collection, participating clinicians were invited to a meeting in 
their place of work to thank them for their participation and give them an opportunity to 
make additional comments regarding assessment of phase. The meetings were recorded 
by the taking of notes. 
The study sample size was calculated to be 400 patient assessments in order to test the 
reliability of the PC Phase. This was based on an expected level of agreement (using the 
Kappa statistic) of 0.75, with a 95% confidence interval from 0.675 to 0.825. This 
calculation assumed (1) an expected agreement between raters of 0.825; (2) the 
probability of raters observing each of the four PC phases based on the most recent 
PCOC data at the time the study was conducted (0.39, 0.26, 0.28 and 0.07 for the stable, 
unstable, deteriorating and terminal phases respectively). 
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The Kappa statistic (k) was used to determine the significance of the level of agreement 
between clinicians. The kappa co-efficient of agreement is the ratio of the proportion of 
times that the clinicians agreed on the PC Phase (corrected for chance agreement) to the 
proportion of times that the clinicians could agree (corrected for chance agreement). 
The Kappa coefficient is based on a measurement scale ranging from +1 (perfect 
agreement) to –1 (complete disagreement), with zero indicating a level of agreement 
that would be expected by chance. The interpretation of the results for the kappa 
coefficient is based on the work of Landis and Koch.8  
The research was approved by the University of Wollongong/Illawarra Shoalhaven 
Local Health District Health and Medical Human Research Ethics Committee (reference 
no. HE12/484). Consent by staff was implied by completing the data collection forms. 
Results 
Patient characteristics 
The 595 matched assessments relate to 410 patients who were assessed during the study 
period. All assessments took place in inpatient units, except for eight assessments 
undertaken in the community. The one community-based service participating in the 
study found it difficult to identify situations where patients could be assessed in 
accordance with the study protocol (i.e. by two clinicians at approximately the same 
time). 
PCOC was able to retrieve demographic data for 281(69%) patients by linking to 
information stored in PCOC’s National Longitudinal database. Two sites would not 
allow medical record numbers to be recorded on the assessment forms, thus reducing 
the ability to link with data in the national database. As seen in Table 1, the study 
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sample was representative of Australian palliative care patients as reported by the 
Palliative Care Outcomes Collaboration in terms of age, gender, diagnosis and preferred 
language spoken at home.9  
Table 1. Patient characteristics. 
  Study  PCOC 
total (%) 
  
n %  
 < 25 0 0  0.4 
Age 
Group 
(years) 
25-54 35 13  11.1 
55-64 36 13  15.8 
65-74 69 25  25.5 
75-84 71 26  27.4 
85+ 66 24  19.8 
Total 277 100  100 
Gender 
Male 147 52  54 
Female 134 48  46 
Total 281 100  100 
Diagnosis 
Malignant 248 88  80.2 
Non-malignant 30 11  18.5 
Not reported 3 1  1.3 
Total 281 100  100 
Preferred 
Language 
English 248 89  85 
Other 30 11  15 
Total 278 100  100 
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Clinician demographics 
Of the 102 participating clinicians, 77 (75%) provided information regarding their 
position title, profession, clinical experience and education in use of the tools. Of those 
who responded, 70 (91%) were nurses and 7 (9%) were doctors (registrars and 
specialists). Fifty-five nurses identified as a registered nurse. PCOC does not routinely 
collect data on the discipline of those completing patient assessments but the high 
proportion of nursing staff is consistent with the most recent profile of the Australian 
palliative care workforce. Based on full-time equivalents, the ratio of nursing staff to 
medical staff working in palliative care across Australia is approximately 9.5:1.10  
Participants had extensive clinical experience, including considerable experience in 
palliative care, with 55% reporting more than 15 years in clinical practice overall and 
23% reporting more than 15 years in palliative care. Similar numbers of clinicians had 
attended a PCOC education workshop as those who received on the job training (Table 
2). Forty-two clinicians (55%) reported having received both formal and on-the-job 
training. 
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Table 2. Clinician demographics. 
Experience All clinical experience Palliative care experience 
 n % n % 
Less than 5 years 19 25 33 43 
5-9 years 9 12 19 25 
10-14 years 6 8 6 8 
15 years or more 42 55 18 23 
Not reported 1 1 1 1 
Total 77 100 77 100 
Training in use of the PCOC tools 
 Education program On-the-job training 
 n % n % 
Less than 3 months ago 9 12 14 18 
3-12 months ago 20 26 23 30 
More than 12 months ago 23 30 17 22 
Time of training not reported 2 3 4 5 
No training 22 29 16 21 
Not reported 1 1 3 4 
Total 77 100 77 100 
 
Inter-rater reliability 
There was a perfect match for 472 (79.3%) of the 595 patients and a mismatch in the 
ratings for 123 patients (Table 3). The most mismatches were for stable/unstable, 
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stable/deteriorating and unstable/deteriorating combinations, with these three types of 
mismatch accounting for 89% of all mismatches. The time interval between the two 
assessments was generally within the 2-hour time frame of the study protocol (Table 3) 
with 90.7% of paired assessments occurring within two hours of each other and 99.6% 
within four hours. The time between ratings did not have a statistically significant effect 
on rater agreement when investigated using a logistic regression model and a 
significance level of 0.05. 
Table 3. Characteristics of ratings by two clinicians. 
 
Rating 1 Rating 2 n %
Median time between 
ratings (minutes) 
Matched 
ratings 
Stable Stable 283 47.6 53.5 
Unstable Unstable 58 9.7 27.5 
Deteriorating Deteriorating 86 14.5 30.0 
Terminal  Terminal 45 7.6 52.5 
Mismatched 
ratings 
Stable Unstable 45 7.6 44.0 
Stable Deteriorating 39 6.6 55.0 
Unstable Deteriorating 26 4.4 60.0 
Deteriorating  Terminal 10 1.7 60.0 
Stable Terminal 2 0.3 95.0 
Unstable Terminal 1 0.2 120.0 
Total 595 100  
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The value of Kappa was 0.67 with a 95% confidence interval of 0.61 to 0.70. When 
analysed according to the 10 participating services, all services achieved at least a 
moderate level of agreement. The services that conducted the smallest and largest 
number of assessments achieved the best level of agreement, with the percentage of 
actual agreement ranging from 94% to 71% (Table 4). 
Table 4. Rater agreement by service. 
Service No. of 
assessments 
% actual 
agreement 
Kappa 95% confidence 
interval 
Strength of 
agreementa 
1 17 94 0.91 (0.74, 1.00) Almost perfect 
2 100 93 0.89 (0.80, 0.97) Almost perfect 
3 26 85 0.73 (0.47, 0.98) Substantial 
4 71 80 0.6 (0.43, 0.78) Moderate 
5 63 79 0.6 (0.42, 0.78) Moderate 
6 53 77 0.5 (0.26, 0.73) Moderate 
7 60 77 0.66 (0.50, 0.82) Substantial 
8 66 73 0.6 (0.44, 0.76) Moderate 
9 76 71 0.59 (0.44, 0.74) Moderate 
10 63 71 0.52 (0.34, 0.69) Moderate 
Overall 595 79 0.67 (0.61, 0.70) Substantial 
a As per Landis and Koch8    
Acceptability 
Table 5 summarises the results for degree of fit and ease of assignment for all 
assessments, including 130 patients assessed by one clinician (69 rated as stable, 22 as 
unstable, 28 as deteriorating and 11 as terminal).  
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Table 5. Degree of fit and ease of assignment by PC Phase. 
Palliative Care 
Phase 
Degree of fit Ease of assignment 
n Mean rating n Mean rating 
Terminal 114 3.84 114 3.80 
Stable 721 3.33 718 3.28 
Deteriorating 275 3.18 275 3.09 
Unstable 210 2.90 210 2.86 
 1320 3.28 1317 3.22 
 
High scores for ‘degree of fit’ indicate a good fit between the phase definition and the 
phase assigned to the patient; high scores for ‘ease of assignment’ indicate that it was 
relatively easy to assign a patient to a PC Phase using the revised definitions. The 
results for all patient assessments (matched and mismatched assessments) indicate a 
consistent pattern, with the terminal phase fitting best with the definition of that phase 
and being the easiest to rate, and the unstable phase having the worst fit and being the 
most difficult to rate.   
Comments by raters 
The data collection form provided an opportunity for participants to comment about 
assessing patients and assigning a PC Phase, resulting in 206 comments from 47 
clinicians. The majority of comments (69%) provided details of the patient being 
assessed, with other comments primarily focusing on how phases are defined (9%) or 
referring to a degree of unfamiliarity with the patient (11%). Comments on 71 
assessments (5% of all assessments) indicated difficulty with the assessment, examples 
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of which are included in Table 6. The table is structured to juxtapose comments with the 
context of those comments e.g. the comments in the last row were both made in 
situations where the patient was considered by one clinician to be unstable and by the 
other clinician to be deteriorating. Even when two clinicians agreed on the assessment 
of phase, it was not necessarily straightforward. For example, the clinician who 
commented that the patient was ‘not quite stable but not unstable’ who assessed the 
patient as stable, as did the other clinician assessing the same patient. All comments in 
Table 6 are by different clinicians, and no two comments are about the same patient. 
Table 6. Examples of comments regarding difficulties assigning PC Phase. 
Clinician ratings Clinician comments 
Two assessments of 
stable 
Stable and slowly deteriorating. 
Multiple comorbidities. Not quite stable but not unstable. 
Two assessments of 
unstable 
Difficult to assign due to patient having periods of sudden deterioration then 
becoming 'stable' again which can really only be described as unstable - but 
greatly varies at times. 
Rapid and urgent are too strong descriptions. The patient has an increase in 
severity of symptoms but are neither rapid or requiring urgent change etc. I 
can't say deteriorating but this has a better description of how I perceive my 
patient. 
Two assessments of 
deteriorating 
Increase in severity of some problems could warrant unstable phase however 
these are known ongoing issues. 
It is probably between deteriorating and terminal. 
One assessment of 
stable, one assessment 
of unstable 
Difficult to gauge patients fluctuating condition. (Stable) 
The patient's condition is improving but in view of ongoing problems and 
possible disease progression issues she continues to be unstable. (Unstable) 
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One assessment of 
stable, one assessment 
of deteriorating 
Patient has been slowly deteriorating, though has been stable throughout. It is 
difficult to assess if she should be stable or deteriorating. (Deteriorating) 
Sometimes it's hard when patients are stable and their pain changes but their 
condition remains stable, but following the disease trajectory. (Stable) 
One assessment of 
unstable, one 
assessment of 
deteriorating 
Difficult to know whether patient should be in unstable or deteriorating phase - 
she has a UTI which would be a new symptom but also could be generally 
deteriorating. (Deteriorating) 
Patient was questionably unstable due to change of FIVD from morph to hydro 
(drowsy) and hypoxic. (Unstable) 
Phase in parenthesis is the phase assigned by the clinician making the comment. 
Feedback from meetings with participating services 
In total, 61 people attended the meetings with participating services, 33 participants, 13 
other clinicians, 10 managers and 5 educators. Discussion primarily focused on the 
issue of which pairings of phases were the most difficult to differentiate. The 
viewpoints expressed on this issue were varied but all instances of difficulty 
differentiating between phases involved the deteriorating phase in some way. Equally, 
there were instances where raters saw the differentiation between each of these pairings 
of phases as ‘very clear’ or ‘not a problem’. No major problems were identified with the 
revised phase definitions, except at one service where concern was expressed at linking 
the definitions of PC Phase to care planning. This same service felt that the definitions 
of the end of each PC Phase were not helpful. 
Discussion and conclusions 
The kappa coefficient in this study (0.67) compares favourably with the only other 
inter-rater reliability study of PC Phase, which reported a kappa of 0.52.2 The overall 
level of agreement was substantial, based on a scale that has been used extensively in 
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palliative care to judge the performance of assessment tools.11-14 The kappa coefficient 
did not quite reach the expected level of 0.75, in part because of differences between the 
distribution of the types of phases observed in the study compared to the distribution 
used to calculate the sample size. 
The mean degree of fit of 3.28 indicates a good fit between patient characteristics and 
the definition of each PC Phase. The mean ‘ease of assignment’ rating of 3.22 indicates 
no significant difficulties assigning patients to a PC Phase. However, the study results 
indicate that it is difficult to classify some patients. This is hardly surprising as no single 
set of definitions can ever capture the full range of patient experiences, with comments 
from clinicians highlighting the challenges of dealing with complexities such as 
comorbidities. Given the overall utility of PC Phase, further research to understand the 
processes involved in assessing these more complex clinical situations is recommended 
to further guide clinical decision making. PCOC’s training program has recently been 
updated, incorporating interactive case studies that provide clinicians with opportunities 
to improve assessment skills in the more challenging clinical situations identified in this 
study.    
In the previous PC Phase inter-rater reliability study, the only requirement was that the 
two assessments were completed on the same day. The time period between 
assessments was not measured.2 One of the strengths of this study is that the two 
assessments of each patient were undertaken within a relatively short period of time 
(90.7% within 2 hours) compared to the average phase length for inpatients across all 
PCOC services of 7.4 days for the stable phase, 2.7 days for the unstable phase, 5.3 days 
for the deteriorating phase and 2.1 days for the terminal phase.9 A further strength of 
this study is that each patient was assessed by two clinicians. In the previous study each 
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patient was assessed by up to seven clinicians, who would inevitably have variable 
levels of familiarity with the patient.  
One of the limitations of the study is that it was restricted to testing inter-rater 
reliability. This was a priority given the recent refinement of the phase definitions but 
there is a need for further research on wider psychometric properties such as validity 
and test-retest reliability. The focus on inpatients was another limitation and further 
research in other settings is warranted. 
Participating services and clinicians had been using the PCOC tools for a long time and 
the majority of clinicians had received training in use of PC Phase (see Table 2). For 
92% of the assessments in this study, the clinician identified (using a yes/no response) 
that there were sufficiently familiar with the patient’s clinical condition to be confident 
about their assessment of the PC Phase. The results of this study may therefore not be 
generalizable to situations where assessment of PC Phase is introduced to a new service 
or clinicians new to palliative care start using the tool. 
In summary, the results of this study demonstrate that PC Phase is a reliable and 
acceptable measure. PC Phase is routinely used in clinical communication, underpins 
the PCOC approach to quality improvement, and is the foundation of the Australian 
national system of activity based funding for palliative care that was introduced in 2012. 
Substantial inter-rater reliability is critical to maintaining the integrity of each of these 
activities. The revised definitions reported here have already been adopted as the 
Australian national standard.15 Similar definitions and concepts are in use or are being 
piloted in other countries as well. 
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Appendix 1: Revised PC Phase definitions 
START END 
1. Stable 
Patient problems and symptoms are adequately 
controlled by established plan of care and 
 Further interventions to maintain symptom 
control and quality of life have been planned 
and 
 Family/carer situation is relatively stable and 
no new issues are apparent 
The needs of the patient and or family/carer 
increase, requiring changes to the existing plan of 
care. 
2. Unstable 
An urgent change in the plan of care or emergency 
treatment is required because 
 Patient experiences a new problem that was 
not anticipated in the existing plan of care, 
and/or 
 Patient experiences a rapid increase in the 
severity of a current problem; and/or 
 Family/ carers circumstances change suddenly 
impacting on patient care 
 The new plan of care is in place, it has been 
reviewed and no further changes to the care 
plan are required. This does not necessarily 
mean that the symptom/crisis has fully 
resolved but there is a clear diagnosis and plan 
of care (i.e. patient is stable or deteriorating) 
and/or 
 Death is likely within days (i.e. patient is now 
terminal) 
3. Deteriorating 
The care plan is addressing anticipated needs but 
requires periodic review because 
 Patients overall functional status is declining 
and 
 Patient experiences a gradual worsening of 
existing problem and/or 
 Patient condition plateaus (ie patient is now 
stable) or 
 An urgent change in the care plan or 
emergency treatment and/or 
 Family/ carers experience a sudden change in 
their situation that impacts on patient care, and 
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 Patient experiences a new but anticipated 
problem and/or 
 Family/carers experience gradual worsening 
distress that impacts on the patient care 
urgent intervention is required (ie patient is 
now unstable) or 
 Death is likely within days (i.e. patient is now 
terminal) 
4. Terminal 
Death is likely within days  Patient dies or 
 Patient condition changes and death is no 
longer likely within days (i.e. patient is now 
stable or deteriorating) 
5. Bereavement – post death support 
 The patient has died 
 Bereavement support provided to family/carers 
is documented in the deceased patient’s 
clinical record 
 Case closure 
Note: If counselling is provided to a family 
member or carer, they become a client in their own 
right 
 
 
